slides · global inventory
Quote
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 18,554
Current window 15,781-15,810
Pages 619
Rows per page 30
Component
15,781-15,810 of 18,554
230
The slide uses a Q&A format to highlight the alleged restriction of professional judgment.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
235
The slide uses a Q&A format to highlight potential ethical concerns regarding data transparency in organ recovery.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
236
The slide uses a Q&A transcript format to support the primary allegation of unethical organ procurement practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
241
The slide uses a quote from Congressman Paul Gosar to substantiate claims of a 'bait and switch' business model.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
244
The slide uses a narrative structure to expose operational risks and employee dissatisfaction.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
246
The slide uses a narrative format to expose operational failures and potential ethical/regulatory concerns regarding TransMedics' high-volume users.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
250
The slide uses strong, emotive language to frame the company's leadership as the primary antagonist.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
253
The slide uses highlighted text to emphasize key quotes from former executives regarding the CEO's professional conduct.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
254
The slide uses direct quotes from former employees and industry contacts to build a negative narrative around the CEO's personality and professional standing.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
257
The slide uses verbatim interview transcripts to substantiate claims of extortion and unprofessional conduct by specific named executives.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
258
The slide uses a Q&A transcript format to highlight negative sentiment regarding company culture and sales practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
259
The slide uses a Q&A format to document allegations of unethical sales pressure by a specific individual (Magdy Attia) at TransMedics.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
260
The slide uses a Q&A format to build a case against the company's business practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
267
The slide uses a combination of summary text and direct interview transcripts to build a case of corporate misconduct.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
268
The slide presents a narrative of professional misconduct and coercion within an organ procurement organization.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
274
The slide uses Q&A transcripts to highlight a shift away from OCS technology in high-volume transplant centers.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
279
The slide uses direct quotes from an UCSF administrator to build a case against TransMedics' long-term viability at the institution.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
280
The slide uses highlighted text to emphasize key negative sentiment regarding TransMedics' sustainability and market position.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
290
The slide uses a Q&A format to highlight the perceived lack of value proposition for the OCS Lung product.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
298
The slide uses a Q&A transcript format to highlight negative expert sentiment.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
299
The slide presents a synthesis of expert commentary followed by verbatim Q&A excerpts highlighting the 'last resort' nature of the current service and the future growth thesis.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
301
The slide uses direct quotes and Q&A transcripts to undermine the clinical value proposition of the TransMedics device.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
302
The slide uses direct quotes to undermine the value proposition of the OCS device.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
319
The slide uses expert testimony to frame TransMedics as an overpriced incumbent being disrupted by a cheaper, established European technique (NRP).TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
322
The slide contrasts the perceived limitations of TransMedics' technology with the functional advantages of NRP, supported by expert testimony and market evidence.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
323
The slide uses a 'canary in the coal mine' metaphor to frame the loss of a major customer as a leading indicator of broader market share erosion.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
327
The slide uses direct quotes from former employees to build a case for corporate malfeasance and product failure.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
329
The slide uses a Q&A transcript format to substantiate claims about corporate governance and safety oversight failures.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
330
The slide uses direct quotes from former employees and industry peers to build a case against the reliability of the TransMedics OCS device.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit
332
The slide presents a Q&A format to highlight a specific technical failure mode (necrosis) attributed to the device's design.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 1 hit